SE385904B - Forfarande for framstellning av 21-adamantoaterna av berametason och dess 9alfa-klor-analog - Google Patents
Forfarande for framstellning av 21-adamantoaterna av berametason och dess 9alfa-klor-analogInfo
- Publication number
- SE385904B SE385904B SE7208817A SE881772A SE385904B SE 385904 B SE385904 B SE 385904B SE 7208817 A SE7208817 A SE 7208817A SE 881772 A SE881772 A SE 881772A SE 385904 B SE385904 B SE 385904B
- Authority
- SE
- Sweden
- Prior art keywords
- berametason
- adamantoats
- 9alfa
- procedure
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3134971A GB1391443A (en) | 1971-07-05 | 1971-07-05 | Ester of betamethasone and its 9alpha-chloro analogue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE385904B true SE385904B (sv) | 1976-07-26 |
Family
ID=10321802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7208817A SE385904B (sv) | 1971-07-05 | 1972-07-04 | Forfarande for framstellning av 21-adamantoaterna av berametason och dess 9alfa-klor-analog |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5644079B1 (sv) |
| AR (2) | AR194120A1 (sv) |
| AU (1) | AU464251B2 (sv) |
| BE (1) | BE785812A (sv) |
| CA (1) | CA983919A (sv) |
| CH (1) | CH609065A5 (sv) |
| DE (1) | DE2232827A1 (sv) |
| DK (1) | DK131474B (sv) |
| FR (1) | FR2144761B1 (sv) |
| GB (1) | GB1391443A (sv) |
| IE (1) | IE36529B1 (sv) |
| IL (1) | IL39821A (sv) |
| NL (1) | NL169882C (sv) |
| NO (1) | NO137754C (sv) |
| PH (1) | PH13195A (sv) |
| SE (1) | SE385904B (sv) |
| ZA (1) | ZA724598B (sv) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5024427A (sv) * | 1973-01-03 | 1975-03-15 | ||
| SE418294B (sv) * | 1974-03-27 | 1981-05-18 | Plurichemie Anstalt | Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester |
| JPS6163976U (sv) * | 1984-10-01 | 1986-05-01 | ||
| DK2444092T3 (en) | 2008-05-28 | 2015-09-28 | Reveragen Biopharma Inc | Non-hormonal steroidmodulatorer of NF-? B for the treatment of disease |
| WO2011127048A2 (en) | 2010-04-05 | 2011-10-13 | Validus Biopharma | NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE |
| US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
| US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
-
0
- BE BE785812D patent/BE785812A/xx not_active IP Right Cessation
-
1971
- 1971-07-05 GB GB3134971A patent/GB1391443A/en not_active Expired
-
1972
- 1972-07-04 NO NO2406/72A patent/NO137754C/no unknown
- 1972-07-04 IE IE939/72A patent/IE36529B1/xx unknown
- 1972-07-04 AU AU44205/72A patent/AU464251B2/en not_active Expired
- 1972-07-04 JP JP6640472A patent/JPS5644079B1/ja active Pending
- 1972-07-04 IL IL39821A patent/IL39821A/xx unknown
- 1972-07-04 CA CA146,248A patent/CA983919A/en not_active Expired
- 1972-07-04 DE DE2232827A patent/DE2232827A1/de not_active Ceased
- 1972-07-04 ZA ZA724598A patent/ZA724598B/xx unknown
- 1972-07-04 DK DK331372AA patent/DK131474B/da unknown
- 1972-07-04 NL NLAANVRAGE7209345,A patent/NL169882C/xx not_active IP Right Cessation
- 1972-07-04 SE SE7208817A patent/SE385904B/sv unknown
- 1972-07-04 AR AR242889A patent/AR194120A1/es active
- 1972-07-04 FR FR7224132A patent/FR2144761B1/fr not_active Expired
- 1972-07-04 CH CH1003472A patent/CH609065A5/xx not_active IP Right Cessation
- 1972-07-05 PH PH13687A patent/PH13195A/en unknown
-
1973
- 1973-05-21 AR AR248131A patent/AR194553A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| IL39821A (en) | 1976-02-29 |
| JPS5644079B1 (sv) | 1981-10-16 |
| CA983919A (en) | 1976-02-17 |
| NL169882C (nl) | 1982-09-01 |
| AU464251B2 (en) | 1975-08-21 |
| AR194553A1 (es) | 1973-07-23 |
| NL169882B (nl) | 1982-04-01 |
| ZA724598B (en) | 1973-03-28 |
| DK131474C (sv) | 1975-12-08 |
| NL7209345A (sv) | 1973-01-09 |
| FR2144761B1 (sv) | 1976-03-05 |
| BE785812A (fr) | 1973-01-04 |
| DK131474B (da) | 1975-07-21 |
| CH609065A5 (en) | 1979-02-15 |
| IL39821A0 (en) | 1972-09-28 |
| GB1391443A (en) | 1975-04-23 |
| AR194120A1 (es) | 1973-06-22 |
| AU4420572A (en) | 1974-01-10 |
| NO137754B (no) | 1978-01-09 |
| IE36529B1 (en) | 1976-11-24 |
| PH13195A (en) | 1980-01-18 |
| IE36529L (en) | 1973-01-05 |
| NO137754C (no) | 1978-04-19 |
| DE2232827A1 (de) | 1973-01-18 |
| FR2144761A1 (sv) | 1973-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE392269B (sv) | Forfarande for framstellning av vissa indanyloxitetrazoler | |
| SE398877B (sv) | Forfarande for framstellning av 14-hydroxi-morfinanderivat | |
| SE395349B (sv) | Blixtlas och forfarande for dess framstellning | |
| SE400292B (sv) | Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat | |
| SE392715B (sv) | Forfarande och anordning for tillverkning av planglas | |
| SE385904B (sv) | Forfarande for framstellning av 21-adamantoaterna av berametason och dess 9alfa-klor-analog | |
| SE417200B (sv) | Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat | |
| SE7600889L (sv) | Forfarande for framstellning av deoxo- och dideoxoprostaglandin-e1 | |
| SE397090B (sv) | Forfarande for framstellning av hydroxipyrimidiner | |
| SE405478B (sv) | Forfarande for framstellning av alfa-sulfoacylcefalosporiner | |
| SE384686B (sv) | Forfarande for framstellning av linkomycinderivat | |
| SE408177B (sv) | Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat | |
| SE387936B (sv) | Forfarande for framstellning av substituerade metoxiaminer | |
| TR17780A (tr) | Mensucat techiz maddelerinin imaline mahsus usul | |
| SE380815B (sv) | Forfarande for framstellning av transparenta sampolyamider | |
| SE380520B (sv) | Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin | |
| SE398123B (sv) | Forfarande for framstellning av metoximetylestern av hetacillin | |
| SE392902B (sv) | Forfarande for framstellning av fenylimidazolidinoner | |
| SE386897B (sv) | Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler | |
| SE392716B (sv) | Forfarande och anordning for tillverkning av planglas | |
| SE397350B (sv) | Forfarande for framstellning av tieno-diazepinderivat | |
| SE405730B (sv) | Forfarande for framstellning av kinazolinderivat | |
| SE395700B (sv) | Forfarande for framstellning av heterocykliska estrar av tienobensopyraner och tiopyranobensopyraner | |
| AR204501A1 (es) | Procedimiento de preparacion de derivados de la tiazolin y benzotiazolin pirimidinona-5 | |
| SE387948B (sv) | Forfarande for framstellning av tiofen |